Randomized controlled trials (RCT) allow scientists to test whether an intervention leads to an outcome of interest. The first clinical trial dates back to 1747 and was conducted by James Lind; although not with the rigor of today, Lind selected 12 participants ravaged with scurvy and allocated in pairs to 6 groups1. The first pair…
Tumor Boards and Multidisciplinary Meetings (MDMs) bring together the team of professionals involved in the diagnosis, treatment and care of cancer patients. Typically they include oncologists, radiologists, cancer surgeons, specialist nurses and relevant physicians such as gastroenterologists or chest physicians. These meetings consider a patient’s symptoms, clinical signs and investigations, and plan tests and treatment…
Continue reading ➞ MedShr Global Tumor Boards launching at ASCO 2018
MedShr is working with CRF to support the Structural Heart Disease Summit 2018, bringing together 10 years of experience from TVT with a live case demonstration course on LAA and PFO in Chicago from 20-23rd June. The event features: Comprehensive training with live cases Tips and tricks for TAVI, mitral, LAA and PFO interventions The…
Continue reading ➞ MedShr and CRF at the Structural Heart Disease Summit 2018!
In April, MedShr attended the Malaria Summit in London in support of the global fight to eradicate the deadly disease for good. https://youtu.be/xCoy2B4UcB4 The event was co-hosted by the Governments of Swaziland and Rwanda and convened by the RBM Partnership to End Malaria and the Bill and Melinda Gates Foundation. In attendance were 12 Heads of State,…
Continue reading ➞ MedShr supporting the fight to eradicate malaria at the Malaria Summit in London
Most doctors have recognised for some time that dividing Diabetes into Type 1 early onset typically requiring insulin therapy and Type 2 late onset doesn’t really define the patterns that we see in clinical practice. In March 2018 a study in the Lancet identified five clusters of diabetes that could revolutionise the way we diagnose…
Continue reading ➞ Redefining diabetes: A leap closer to understanding this complex disease
The European Congress of Radiology 2018 saw a record number of delegates and companies gather in Vienna from 28th February to 4th March for one of the biggest and most innovative scientific meetings in Europe hosted by the largest radiological society in the world, the European Society of Radiology (ESR). A total of 28,474 participants…
Continue reading ➞ European Congress of Radiology 2018: Clinical Highlights
This year’s American Academy of Orthopaedic Surgeons Annual Meeting took place in New Orleans from 6th to 10th March and saw attendees from all over the globe congregate for an outstanding educational and professional development experience focusing on the latest research and advancement in orthopaedic surgery. An incredible spectrum of hot topics in the field and…
Continue reading ➞ AAOS 2018 Annual Meeting: Clinical Highlights
Scientific research often boils down to a p-value; p-values are replete within medical journals, conferences, and scientific discussions. Importantly, research evidence interpreted using the p guide policy and practice. What is a p-value and what does it mean? The p stands for the probability of observed difference due to chance under an assumption, classically called…
Continue reading ➞ Demystifying Statistics in Medicine – the p-value
We’re excited to announce a new collaboration with the Cardiovascular Research Foundation, which will be launched at the CTO Summit 2018 in New York in February! The CTO Summit Live Case Course brings together leaders in the fields of CTO intervention between 15-16th February in New York. First hand knowledge through live cases Tips and tricks…
Continue reading ➞ MedShr and CRF collaboration to launch at Chronic Total Occlusion Summit 2018!
The last session of TCT is a half day that includes Late Breaking Clinical Trials. Often sparsely attended, in recent years trials have also been simultaneously published in a peer-reviewed journal and immediately discussed in the press and on social media. The ORBITA study was a first: a placebo-controlled trial comparing PCI to a sham…
Continue reading ➞ Let’s take a look at those ORBITA Angiograms…
